Brooklyn Immunotherapeutics Inc reports results for the quarter ended in December - Earnings Summary

Ernexa Therapeutics

15/04/2022 22:35

* Brooklyn Immunotherapeutics Inc  BTX.OQ  reported a
quarterly
adjusted loss of 16 cents​​ per share for the quarter ended in
December. The mean expectation of two analysts for the quarter
was for a loss of 12 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Brooklyn Immunotherapeutics Inc's reported EPS for the
quarter
was a loss of 16 cents​.
    * The mean earnings estimate of analysts had fallen by
about 19%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Brooklyn Immunotherapeutics Inc shares had fallen by 17.1%
this
quarter and lost 59.2% so far this year.
    * The company reported a quarterly loss of $8.47 million.
    * Wall Street's median 12-month price target for Brooklyn
Immunotherapeutics Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 15 at 09:34 p.m.  ​All
figures in US dollars unless otherwise stated